Published in Biomacromolecules on August 17, 2015
Effect of noncovalent interaction on the self-assembly of a designed peptide and its potential use as a carrier for controlled bFGF release. Int J Nanomedicine (2017) 0.75
Square channels formed by a peptide derived from transthyretin. Chem Sci (2016) 0.75
Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture. Anal Biochem (2017) 0.75
Peptide-Based Supramolecular Hydrogels for Delivery of Biologics. Bioeng Transl Med (2016) 0.75
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A (1976) 21.06
Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87
Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J Cell Biol (1985) 3.16
Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc Natl Acad Sci U S A (2007) 2.87
Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J Am Chem Soc (2002) 2.83
Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev (2006) 2.73
Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc Natl Acad Sci U S A (2009) 1.98
Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de novo designed peptide. J Am Chem Soc (2003) 1.96
Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res (2001) 1.69
Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev (2011) 1.67
Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A (1974) 1.64
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Self-assembling materials for therapeutic delivery. Acta Biomater (2008) 1.51
Biodegradable injectable in situ forming drug delivery systems. J Control Release (2002) 1.50
Rapid, sequential changes in surface morphology of PC12 pheochromocytoma cells in response to nerve growth factor. J Cell Biol (1979) 1.48
Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels. Biomaterials (2008) 1.42
Semiflexible chain networks formed via self-assembly of beta-hairpin molecules. Phys Rev Lett (2004) 1.33
Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials (2011) 1.30
Slow and sustained release of active cytokines from self-assembling peptide scaffolds. J Control Release (2010) 1.27
The effect of protein structure on their controlled release from an injectable peptide hydrogel. Biomaterials (2010) 1.23
Probing the importance of lateral hydrophobic association in self-assembling peptide hydrogelators. Eur Biophys J (2005) 1.17
Modulation of protein delivery from modular polymer scaffolds. Biomaterials (2006) 1.16
Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels. Soft Matter (2010) 1.14
Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91(PHOX) and p67(PHOX). J Biol Chem (2006) 1.07
Local delivery of proteins and the use of self-assembling peptides. Drug Discov Today (2007) 1.05
Direct Observation of Early-Time Hydrogelation in beta-Hairpin Peptide Self-Assembly. Macromolecules (2008) 1.04
Tunable mechanical stability and deformation response of a resilin-based elastomer. Biomacromolecules (2011) 1.02
Injectable hydrogel materials for spinal cord regeneration: a review. Biomed Mater (2012) 1.02
Tuning the pH responsiveness of beta-hairpin peptide folding, self-assembly, and hydrogel material formation. Biomacromolecules (2009) 1.00
Evolving the use of peptides as components of biomaterials. Biomaterials (2011) 0.99
Bioengineering approaches to controlled protein delivery. Pediatr Res (2008) 0.95
Peptide-based and polypeptide-based hydrogels for drug delivery and tissue engineering. Top Curr Chem (2012) 0.92
Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma. PLoS One (2013) 0.91
The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization. Br J Haematol (2011) 0.91
Effect of chemistry and morphology on the biofunctionality of self-assembling diblock copolypeptide hydrogels. Biomacromolecules (2004) 0.88
Potential role of growth factors in the management of spinal cord injury. World Neurosurg (2013) 0.86
Stem-cell niche based comparative analysis of chemical and nano-mechanical material properties impacting ex vivo expansion and differentiation of hematopoietic and mesenchymal stem cells. Adv Healthc Mater (2012) 0.83
Nanomechanics controls neuronal precursors adhesion and differentiation. Biotechnol Bioeng (2013) 0.83
Platelets from mice lacking the aryl hydrocarbon receptor exhibit defective collagen-dependent signaling. J Thromb Haemost (2014) 0.81
Doxorubicin loaded magneto-niosomes for targeted drug delivery. Colloids Surf B Biointerfaces (2012) 0.80
Rheology of peptide- and protein-based physical hydrogels: are everyday measurements just scratching the surface? Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.79
Neurotrophins and spinal circuit function. Front Neural Circuits (2014) 0.79
Design of self-assembling peptide hydrogelators amenable to bacterial expression. Biomaterials (2014) 0.76
Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia. J Clin Invest (2008) 1.33
Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia. J Biol Chem (2008) 1.09
Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. Mol Cell Biol (2006) 1.07
Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis. J Biol Chem (2008) 0.94
Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol (2009) 0.93
Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma. PLoS One (2013) 0.91
Hydrocephalus. Pediatr Clin North Am (2004) 0.86
Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis. BMC Cancer (2012) 0.85
Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care (2006) 0.82
Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells. Exp Eye Res (2013) 0.82
Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation. Physiol Genomics (2012) 0.82
Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. J Cell Sci (2012) 0.82
Incidental findings on brain and spine imaging in children. Pediatrics (2015) 0.81
A 2-year follow-up of outcomes following orthopedic surgery or selective dorsal rhizotomy in children with spastic diplegia. J Pediatr Orthop B (2004) 0.79
Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol (2012) 0.79
Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features. Pediatr Neurol (2005) 0.79
Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma. Cancer Med (2014) 0.78
Selective dorsal rhizotomy versus orthopedic surgery: a multidimensional assessment of outcome efficacy. Arch Phys Med Rehabil (2004) 0.78
Surgical management of the Chiari malformation Type I: the way forward. J Neurosurg Pediatr (2008) 0.78
Sustained release of active chemotherapeutics from injectable-solid β-hairpin peptide hydrogel. Biomater Sci (2016) 0.77
Posthemorrhagic ventricular dilation. J Neurosurg Pediatr (2010) 0.76
Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation. J Leukoc Biol (2007) 0.76
Glutaric aciduria type 1 and nonaccidental head injury. Pediatrics (2002) 0.76
Ultrasonographic screening in infants with isolated spinal strawberry nevi. J Neurosurg (2003) 0.75
Quality measures for the management of hydrocephalus: concepts, simulations, and preliminary field-testing. J Neurosurg Pediatr (2013) 0.75
Response. J Neurosurg Pediatr (2015) 0.75
A multicenter study of factors influencing cerebrospinal fluid shunt survival in infants and children. Neurosurgery (2009) 0.75
Tethered cord release. J Neurosurg Pediatr (2009) 0.75
Survival of shunts. J Neurosurg (2007) 0.75
Ultrasound guidance. J Neurosurg Pediatr (2008) 0.75
Cervical spine clearance. J Neurosurg Pediatr (2010) 0.75
Peritoneal cerebrospinal fluid shunt insertion. J Neurosurg (2004) 0.75
"Never events" come to neurosurgery. J Neurosurg (2010) 0.75
Skin hemangiomas and occult dysraphism. J Neurosurg (2004) 0.75
Editorial. Neurosurgical education for pediatricians. J Neurosurg Pediatr (2009) 0.75
Conflict of interest. J Neurosurg (2010) 0.75
Dorsal rhizotomy. J Neurosurg (2006) 0.75
Fracture of the anterior arch of atlas after minor trauma of the immature spine postlaminectomy. Pediatr Emerg Care (2014) 0.75
Objective measurement of muscle strength in children with spastic diplegia after selective dorsal rhizotomy. Arch Phys Med Rehabil (2002) 0.75
Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature. J Child Neurol (2011) 0.75